
It's called Trikafta, and people living with Cystic Fibrosis describe it as a true game-changer. It can treat symptoms at the source rather than manage them endlessly every day. It was approved in the United States in 2019 but only arrived in most Canadian provinces a few months ago. Why did it take so long? How does this drug work? And is the approval process it went through a precedent of better days to come for Canada's health care system?
GUEST: Jeremie Saunders, host of Sickboy, living with Cystic Fibrosis
We love feedback at The Big Story, as well as suggestions for future episodes. You can find us:
Through email at [email protected]
Or @thebigstory.bsky.social on Bluesky
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Mais episódios de "The Big Story"



Não percas um episódio de “The Big Story” e subscrevê-lo na aplicação GetPodcast.








